Multi-omic profiling of TKI resistant K562 cells suggests metabolic reprogramming to promote cell survival

No abstract is available for this paper.

• Publication year

  2018

• Venue

  bioRxiv

• Publication date

  2018-05-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1101/308528
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Present results and future perspectives in optimizing chronic myeloid leukemia therapy

  2018cited by this paper
• Metabolic Reprogramming During Multidrug Resistance in Leukemias

  2018cited by this paper
• Altered intracellular signaling by imatinib increases the anti‐cancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia cells

  2017cited by this paper
• Resistance Is Futile: Targeting Mitochondrial Energetics and Metabolism to Overcome Drug Resistance in Cancer Treatment.

  2017cited by this paper
• Metabolic Reprogramming in Glioma

  2017cited by this paper
• Combined inhibition of β-catenin and Bcr–Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo

  2017cited by this paper
• Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles

  2017cited by this paper
• Current and upcoming mitochondrial targets for cancer therapy.

  2017cited by this paper
• The clinical significance of ABCB1 overexpression in predicting outcome of CML patients undergoing first-line imatinib treatment

  2017cited by this paper
• Cancer metabolism: a therapeutic perspective

  2017cited by this paper
• Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism.

  2017cited by this paper
• Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogramming

  2017cited by this paper
• A Genome-wide CRISPR Death Screen Identifies Genes Essential for Oxidative Phosphorylation.

  2016cited by this paper
• Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor–Sensitive and -Resistant Chronic Myeloid Leukemia

  2016cited by this paper
• Heatmapper: web-enabled heat mapping for all

  2016cited by this paper
• Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche.

  2016cited by this paper
• Hypoxia-Inducible Factors: Master Regulators of Cancer Progression.

  2016cited by this paper
• Oncogenic regulation of tumor metabolic reprogramming

  2016cited by this paper
• Hematopoietic stem/progenitor cell commitment to the megakaryocyte lineage.

  2016cited by this paper
• AGC1/2, the mitochondrial aspartate-glutamate carriers.

  2016cited by this paper
• The metabolomic signature of hematologic malignancies.

  2016cited by this paper
• A Cell-Based Assay for Measuring Endogenous BcrAbl Kinase Activity and Inhibitor Resistance

  2016cited by this paper
• Dasatinib in imatinib‐resistant or ‐intolerant chronic‐phase, chronic myeloid leukemia patients: 7‐year follow‐up of study CA180‐034

  2016cited by this paper
• Convergence of Parkin, PINK1, and α-Synuclein on Stress-induced Mitochondrial Morphological Remodeling*

  2015cited by this paper
• MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins

  2015cited by this paper
• Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia

  2015cited by this paper
• α-Synuclein Shows High Affinity Interaction with Voltage-dependent Anion Channel, Suggesting Mechanisms of Mitochondrial Regulation and Toxicity in Parkinson Disease*

  2015cited by this paper
• Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets

  2015cited by this paper
• Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in acute lymphoblastic leukemia

  2015cited by this paper
• The pentose phosphate pathway and cancer.

  2014cited by this paper
• Intracellular Carbonic Anhydrase Activity Sensitizes Cancer Cell pH Signaling to Dynamic Changes in CO2 Partial Pressure*

  2014cited by this paper
• The chemistry, physiology and pathology of pH in cancer

  2014cited by this paper
• α‐synuclein‐induced mitochondrial dysfunction in isolated preparation and intact cells: Implications in the pathogenesis of Parkinson's disease

  2014cited by this paper
• NUP214 fusion genes in acute leukemia (Review)

  2014cited by this paper
• Application of Multiplexed Kinase Inhibitor Beads to Study Kinome Adaptations in Drug-Resistant Leukemia

  2013cited by this paper
• Perspective: Combined forces

  2013cited by this paper
• The dynamic nature of the kinome.

  2013cited by this paper
• Causal analysis approaches in Ingenuity Pathway Analysis

  2013cited by this paper
• Resistance to tyrosine kinase inhibition therapy for chronic myelogenous leukemia: a clinical perspective and emerging treatment options.

  2013cited by this paper
• Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose.

  2013cited by this paper
• [Chronic myelogenous leukemia].

  2013cited by this paper
• Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis*

  2012cited by this paper
• Mechanisms of AXL overexpression and function in Imatinib-resistant chronic myeloid leukemia cells

  2011cited by this paper
• The Pentose Phosphate Pathway Is a Metabolic Redox Sensor and Regulates Transcription During the Antioxidant Response

  2011cited by this paper
• Alpha‐ and beta‐synucleins are new diagnostic tools for acute erythroid leukemia and acute megakaryoblastic leukemia

  2011cited by this paper
• deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data

  2011cited by this paper
• Pyruvate Kinase Triggers a Metabolic Feedback Loop that Controls Redox Metabolism in Respiring Cells

  2011cited by this paper
• Imatinib-resistance associated with BCR-ABL upregulation is dependent on HIF-1α-induced metabolic reprogramming

  2010cited by this paper
• Prolyl hydroxylases as regulators of cell metabolism.

  2009cited by this paper
• Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism.

  2009cited by this paper
• The use of nilotinib or dasatinib after failure to 2 prior tyrosine kinase inhibitors: long-term follow-up.

  2009cited by this paper
• Open Access Method

  2009cited by this paper
• Spontaneous mapping of number and space in adults and young children.

  2009cited by this paper
• Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitors

  2009cited by this paper
• Measurement of in vivo BCR-ABL kinase inhibition to monitor imatinib-induced target blockade and predict response in chronic myeloid leukemia.

  2007cited by this paper
• 9 – Minor Carbohydrate Pathways: Ribose, Fructose, and Galactose

  2007cited by this paper
• Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance.

  2006cited by this paper
• Cytochrome P450 Profile of Colorectal Cancer: Identification of Markers of Prognosis

  2005cited by this paper
• Imatinib (STI571)-Mediated Changes in Glucose Metabolism in Human Leukemia BCR-ABL-Positive Cells

  2004cited by this paper
• Quantitative metabolome analysis using capillary electrophoresis mass spectrometry.

  2003cited by this paper
• Simultaneous determination of anionic intermediates for Bacillus subtilis metabolic pathways by capillary electrophoresis electrospray ionization mass spectrometry.

  2002cited by this paper
• Amino acid analysis by capillary electrophoresis electrospray ionization mass spectrometry.

  2000cited by this paper
• Nonviability of cells with oxidative defects in galactose medium: a screening test for affected patient fibroblasts.

  1992cited by this paper
• The Crabtree effect: a review.

  1961cited by this paper
• Expanded View Figures

  year unknowncited by this paper

• Investigating the potential therapeutic role of targeting STAT3 for overcoming drug resistance by regulating energy metabolism in chronic myeloid leukemia cells

  2022cites this paper
• Metabolic Plasticity Is an Essential Requirement of Acquired Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia

  2020cites this paper
• Protective autophagy or autophagic death: effects of BEZ235 on chronic myelogenous leukemia

  2019cites this paper
• CMAR_A_204472 7933..7951

  2019cites this paper